Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

53
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
53
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

16.0K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.0K
Genetic Screens02:46

Genetic Screens

5.8K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.8K
Human Genetics01:28

Human Genetics

1.7K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic underpinnings of the heterogeneous impact of obesity on lipid levels and cardiovascular disease.

Genome medicine·2025
Same author

Polygenic risk score for type 2 diabetes shows context-dependent effects across populations.

Nature communications·2025
Same author

Genetic architecture and analysis practices of circulating metabolites in the NHLBI Trans-Omics for Precision Medicine Program.

American journal of human genetics·2025
Same author

Genome-wide association study provides novel insight into the genetic architecture of severe obesity.

PLoS genetics·2025
Same author

Whole genome sequence analysis of low-density lipoprotein cholesterol across 246 K individuals.

Genome biology·2025
Same author

An Efficient Lasso Framework for Admixture-Aware Polygenic Scores.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Feb 28, 2026

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

19.5K

Risk prediction using genome-wide association studies.

Charles Kooperberg1, Michael LeBlanc, Valerie Obenchain

  • 1Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA. clk@fhcrc.org

Genetic Epidemiology
|September 16, 2010
PubMed
Summary
This summary is machine-generated.

Genome-wide association studies (GWAS) can improve disease risk prediction by including more genetic variants. Utilizing a larger number of single nucleotide polymorphisms (SNPs), even those with small effects, enhances predictive model construction.

More Related Videos

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.8K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.6K

Related Experiment Videos

Last Updated: Feb 28, 2026

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

19.5K
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.8K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.6K

Area of Science:

  • Genetics
  • Bioinformatics
  • Epidemiology

Background:

  • Genome-wide association studies (GWAS) have identified numerous genetic associations.
  • The utility of these variants for disease risk prediction is debated due to small individual effect sizes.
  • Including more variants may enhance prediction accuracy by aggregating weak signals.

Purpose of the Study:

  • To investigate methods for constructing disease probability estimation models using GWAS data.
  • To compare different model construction techniques and the impact of cross-validation.
  • To identify the most effective single nucleotide polymorphisms (SNPs) for prediction.

Main Methods:

  • Analysis of GWAS data from the Welcome Trust Case Control Consortium.
  • Application of the lasso method for SNP selection and model building.
  • Validation of findings using a separate GWAS dataset for Crohn's disease.

Main Results:

  • Models incorporating a larger set of SNPs, beyond genome-wide significance thresholds, demonstrate improved risk prediction.
  • The lasso method proves effective in constructing robust prediction models.
  • Results were confirmed for Crohn's disease prediction.

Conclusions:

  • Including a greater number of SNPs, particularly through methods like lasso, enhances the accuracy of disease risk prediction models.
  • GWAS data holds significant potential for personalized medicine and understanding disease etiology.
  • Further research into optimizing prediction models using comprehensive genetic data is warranted.